Validating a clinical prediction score for Legionella-related community acquired pneumonia
Abstract Background Legionella-related community acquired pneumonia (CAP) is a disease with an increasing incidence and a high mortality rate, especially if empirical antibiotic therapy is inadequate. Antibiotic treatment highly relies on clinical symptoms, although proven non-specific, because curr...
Main Authors: | Rosalie R. A. L. Beekman, Ruud R. Duijkers, Dominic D. Snijders, Menno M. van der Eerden, Martijn M. Kross, Wim W. G. Boersma |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2022-05-01
|
Series: | BMC Infectious Diseases |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12879-022-07433-z |
Similar Items
-
Legionella pneumonia due to non-Legionella pneumophila serogroup 1: usefulness of the six-point scoring system
by: Akihiro Ito, et al.
Published: (2017-12-01) -
Legionella-Like and Other Amoebal Pathogens as Agents of Community-Acquired Pneumonia
by: Thomas J. Marrie, et al.
Published: (2001-12-01) -
Community acquired pneumonia due to Legionella pneumophila in a tertiary care hospital
by: BN Dissanayake, et al.
Published: (2016-10-01) -
Efficacy of omadacycline in the treatment of Legionella pneumonia: a case report
by: Yao Wang, et al.
Published: (2024-05-01) -
Urinary antigene and PCR can both be used to detect Legionella pneumophila in children's hospital-acquired pneumonia
by: Sayed-Yousef Mojtahedi, et al.
Published: (2019-05-01)